Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Revealing dendritic cell-CD4+ T cell communication by using synthetic biology in vivo

Project description

Scientist sleuths track activated T cells and their informants in vivo

Dendritic cells (DCs) of the immune system initiate the adaptive immune response and play an important role in inflammation and its homeostasis. Much like a policeman presenting a suspect's clothing to a police dog, DCs capture and process pathogens and present identifiers (antigens) to the T cells to unleash the T-cell response. Discovered nearly half a century ago, T cells are now known to be a heterogeneous group of cells in both structure and function. However, the significance of these differences remains to be seen. The EU-funded SYNVIVO project, with its established technique to label interactions between immune cells in vivo, is tracking activated T cells to determine the relationship between their fate and the DCs that activated them.

Objective

CD4+ T cells are crucial component of our immune system: they support distinct types of proinflammatory responses key for pathogen clearance, maintain tolerance and suppress harmful inflammation. To perform this multitude of functions, naïve CD4+ T cells first undergo activation through direct contact with dendritic cells (DCs), a highly heterogeneous compartment including several populations of migratory and resident cells. These interactions lead to selection of antigen specific T cell clones, followed by their proliferation and differentiation into distinct subsets showing specialized effector programs or polarizations. Despite the essential role of dendritic cells in the activation and polarization of naïve CD4+ T cells, we have limited information available on both the identity of DC involved in priming and the molecular messages exchanged upon DC-CD4+ T cell interaction in different types of response. Recently, I developed an innovative technology that allows us for the first time to label interactions between immune cells in vivo. This method, which we called LIPSTIC, relies on the labeling of genetically engineered receptor–ligand pairs mediated by the enzyme Sortase A. After the enzymatic reaction takes place in vivo, the history of ligand–receptor interactions is revealed by the presence of reporter tags easily detected by flow cytometry. This proposal aims to determine how interactions between dendritic cells and T cells instruct CD4+ T cells toward distinct fates using LIPSTIC and by implementing other technologies designed ad hoc to measure and understand the biological consequences of relevant cell-cell interactions on T cell fate decision. The combined approaches described here will contribute to the characterization of the molecular signals governing CD4+ T cell response in vivo.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2019-STG

See all projects funded under this call

Host institution

UNIVERSITA DEGLI STUDI DI PADOVA
Net EU contribution
€ 1 500 000,00
Address
VIA 8 FEBBRAIO 2
35122 Padova
Italy
Region
Nord-Est Veneto Padova
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 500 000,00

Beneficiaries (1)